Maintenance of the synergistic effects of cord blood cells and erythropoietin combination therapy after additional cord blood infusion in children with cerebral palsy: 1-year open-label extension study of randomized placebo-controlled trial.
Mi Ri SuhKyunghoon MinKye Hee ChoJongwook KimIkhyun LimMijin ParkEun-Min NohMin Young KimPublished in: Stem cell research & therapy (2023)
CHA Bundang Medical Center IRB, No. 2015-06-093, approved on July 29, 2015, ( https://www.e-irb.com:3443/devlpg/nlpgS200.jsp ), ClinicalTrials.gov, NCT03130816, retrospectively registered on April 27, 2017 ( https://clinicaltrials.gov/ct2/show/NCT03130816?term=NCT03130816&draw=2&rank=1 ).
Keyphrases
- cord blood
- open label
- combination therapy
- children with cerebral palsy
- double blind
- phase ii
- phase iii
- induced apoptosis
- clinical trial
- study protocol
- cell cycle arrest
- placebo controlled
- computed tomography
- preterm infants
- image quality
- randomized controlled trial
- contrast enhanced
- dual energy
- oxidative stress
- endoplasmic reticulum stress
- radiation therapy
- positron emission tomography
- pi k akt